RE: Sunday read12 May 2025 06:42
But, but , but they said this in January. So sometime between mid January and the end of March they started. We don’t know any more.
‘ Avacta has initiated three Phase 1b expansion cohorts in triple negative breast cancer, soft tissue sarcoma and salivary gland cancer in the first and second line setting. Patients are screening and the first patients to be treated in these expansions are expected imminently in the US’